J&J Withdraws Morcellators Due to Cancer Risk
On July 30th, Johnson & Johnson announced that they are voluntarily withdrawing their laparoscopic power morcellators from the market due to risk of spreading malignant tumors.
About the Morcellator Device Recall
Medscape reports that Ethicon, the J&J department that markets the morcellators, stated that the company is withdrawing morcellators because it is still uncertain over the risks and benefits of the device.
J&J had already halted sale the morcellators in late April following an FDA warning that devices might spread occult cancer. Ethicon stressed that they are not recalling the device as a recall would insinuate a performance problem. Ethicon claims the devices are performing exactly as intended.
Earlier this month, an FDA advisory panel supported putting a boxed warning label in morcellator boxes with information regarding the potential cancer risks. Doctors do not want morcellators to be banned, only improved.
Cervical Cancer Statistics in the United States – 2014
- According to WebMD, cervical cancer rates are much higher than years before, especially among women around 60-years-old, and black women.
- Previous studies showed that the overall rate of cervical cancer was 12 cases per 100,000 women, with the highest rates among women between 40-44 years old.
- More recent studies found that the overall rate of cervical cancer was 18.6 cases per 100,000 women, with the highest rates among women between 65-69 years old.
- The incidence of cancer among women around 65-69 year old, are 84% higher than previously believed.
- Studies show that women have higher rates of cervical cancer after being exposed to hysterectomy.